Division of Women's Health, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
Harvard Medical School, Boston, MA, USA.
BMJ. 2023 Aug 8;382:e072612. doi: 10.1136/bmj-2022-072612.
Most women worldwide experience menopausal symptoms during the menopause transition or postmenopause. Vasomotor symptoms are most pronounced during the first four to seven years but can persist for more than a decade, and genitourinary symptoms tend to be progressive. Although the hallmark symptoms are hot flashes, night sweats, disrupted sleep, and genitourinary discomfort, other common symptoms and conditions are mood fluctuations, cognitive changes, low sexual desire, bone loss, increase in abdominal fat, and adverse changes in metabolic health. These symptoms and signs can occur in any combination or sequence, and the link to menopause may even be elusive. Estrogen based hormonal therapies are the most effective treatments for many of the symptoms and, in the absence of contraindications to treatment, have a generally favorable benefit:risk ratio for women below age 60 and within 10 years of the onset of menopause. Non-hormonal treatment options are also available. Although a symptom driven treatment approach with individualized decision making can improve health and quality of life for midlife women, menopausal symptoms remain substantially undertreated by healthcare providers.
全球大多数女性在围绝经期或绝经后会经历更年期症状。血管舒缩症状在绝经前 4 至 7 年内最为明显,但可持续 10 年以上,生殖泌尿系统症状往往呈进行性发展。虽然标志性症状是热潮红、盗汗、睡眠中断和生殖泌尿系统不适,但其他常见的症状和疾病包括情绪波动、认知变化、性欲低下、骨丢失、腹部脂肪增加以及代谢健康的不良变化。这些症状和体征可能以任何组合或顺序出现,与绝经的联系甚至可能难以捉摸。基于雌激素的激素疗法是治疗许多症状的最有效方法,并且在没有治疗禁忌症的情况下,对于 60 岁以下和绝经后 10 年内的女性,其益处与风险的比值通常是有利的。也有非激素治疗选择。尽管采用基于症状的个体化决策治疗方法可以改善中年女性的健康和生活质量,但医疗保健提供者对更年期症状的治疗仍远远不足。